Trial
NCT03810911
Mechanisms of EPO-induced Hypertension
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
VA Office of Research and Development
Collaborators
—
Condition
Chronic Kidney Disease
Intervention
Darbepoetin
Why stopped
The trial was stopped because of inability to reach target sample size.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-15